

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Are we underutilizing bone marrow and cord blood?... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-26/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-26" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies" />
    
            <meta name="og:title" content="F1000Research Article: Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies.">
            <meta name="og:description" content="Read the latest article version by Elisabetta Xue, Filippo Milano, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="22656">
            <meta name="article-id" content="20605">
            <meta name="dc.title" content="Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies">
            <meta name="dc.description" content="Since the first hematopoietic stem cell transplant, over a million transplants have been performed worldwide. In the last decade, the transplant field has witnessed a progressive decline in bone marrow and cord blood utilization and a parallel increase in peripheral blood as a source of stem cells. Herein, we review the use of bone marrow and cord blood in the hematopoietic stem cell transplant setting, and we describe the recent advances made in different medical fields using cells derived from cord blood and bone marrow.">
            <meta name="dc.subject" content="Cord Blood, Bone Marrow, Hematopoietic Stem Cell Transplant, Immunotherapy, Regenerative Medicine">
            <meta name="dc.creator" content="Xue, Elisabetta">
            <meta name="dc.creator" content="Milano, Filippo">
            <meta name="dc.date" content="2020/01/17">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.20605.1">
            <meta name="dc.source" content="F1000Research 2020 9:26">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Cord Blood">
            <meta name="prism.keyword" content="Bone Marrow">
            <meta name="prism.keyword" content="Hematopoietic Stem Cell Transplant">
            <meta name="prism.keyword" content="Immunotherapy">
            <meta name="prism.keyword" content="Regenerative Medicine">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/01/17">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="26">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.20605.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-26">
            <meta name="citation_title" content="Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies">
            <meta name="citation_abstract" content="Since the first hematopoietic stem cell transplant, over a million transplants have been performed worldwide. In the last decade, the transplant field has witnessed a progressive decline in bone marrow and cord blood utilization and a parallel increase in peripheral blood as a source of stem cells. Herein, we review the use of bone marrow and cord blood in the hematopoietic stem cell transplant setting, and we describe the recent advances made in different medical fields using cells derived from cord blood and bone marrow.">
            <meta name="citation_description" content="Since the first hematopoietic stem cell transplant, over a million transplants have been performed worldwide. In the last decade, the transplant field has witnessed a progressive decline in bone marrow and cord blood utilization and a parallel increase in peripheral blood as a source of stem cells. Herein, we review the use of bone marrow and cord blood in the hematopoietic stem cell transplant setting, and we describe the recent advances made in different medical fields using cells derived from cord blood and bone marrow.">
            <meta name="citation_keywords" content="Cord Blood, Bone Marrow, Hematopoietic Stem Cell Transplant, Immunotherapy, Regenerative Medicine">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Elisabetta Xue">
            <meta name="citation_author_institution" content="Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA, 98109, USA">
            <meta name="citation_author_institution" content="Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute IRCCS, Milan, Italy">
            <meta name="citation_author" content="Filippo Milano">
            <meta name="citation_author_institution" content="Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA, 98109, USA">
            <meta name="citation_publication_date" content="2020/01/17">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="26">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.20605.1">
            <meta name="citation_firstpage" content="26">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-26/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-26.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=22656 /> <input type=hidden id=articleId name=articleId value=20605 /> <input type=hidden id=xmlUrl value="/articles/9-26/v1/xml"/> <input type=hidden id=xmlFileName value="-9-26-v1.xml"> <input type=hidden id=article_uuid value=2f2e5087-1153-46f1-a43f-bd0f226b0720 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.20605.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.20605.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-26"
  },
  "headline": "Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular...",
  "datePublished": "2020-01-17T09:59:39",
  "dateModified": "2020-01-17T09:59:39",
  "author": [
    {
      "@type": "Person",
      "name": "Elisabetta Xue"
    },    {
      "@type": "Person",
      "name": "Filippo Milano"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Since the first hematopoietic stem cell transplant, over a million transplants have been performed worldwide. In the last decade, the transplant field has witnessed a progressive decline in bone marrow and cord blood utilization and a parallel increase in peripheral blood as a source of stem cells. Herein, we review the use of bone marrow and cord blood in the hematopoietic stem cell transplant setting, and we describe the recent advances made in different medical fields using cells derived from cord blood and bone marrow."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-26",
            "name": "Are we underutilizing bone marrow and cord blood? Review of their..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Are we underutilizing bone marrow and cord blood? Review of their... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=22656 data-id=20605 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20605.1" data-recommended="" data-doi="10.12688/f1000research.20605.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-26/v1/pdf?article_uuid=2f2e5087-1153-46f1-a43f-bd0f226b0720" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-20605-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-20605-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-20605-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Xue E and Milano F. Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):26 (<a class=new-orange href="https://doi.org/10.12688/f1000research.20605.1" target=_blank>https://doi.org/10.12688/f1000research.20605.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-20605-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=20605 id=track-article-signin-20605 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20605?target=/articles/9-26">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22656 /> <input name=articleId type=hidden value=20605 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Elisabetta Xue<a href="https://orcid.org/0000-0002-1963-9555" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1963-9555</div><sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:fmilano@fredhutch.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Filippo Milano</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Elisabetta Xue<a href="http://orcid.org/0000-0002-1963-9555" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1963-9555</div><sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:fmilano@fredhutch.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Filippo Milano</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 17 Jan 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.20605.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA, 98109, USA<br/> <sup>2</sup> Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute IRCCS, Milan, Italy<br/> <p> <div class=margin-bottom> Elisabetta Xue <br/> <span>Roles: </span> Conceptualization, Formal Analysis, Investigation, Resources, Visualization, Writing – Original Draft Preparation </div> <div class=margin-bottom> Filippo Milano <br/> <span>Roles: </span> Conceptualization, Investigation, Project Administration, Resources, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=62072-58279></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=62071-58278></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Since the first hematopoietic stem cell transplant, over a million transplants have been performed worldwide. In the last decade, the transplant field has witnessed a progressive decline in bone marrow and cord blood utilization and a parallel increase in peripheral blood as a source of stem cells. Herein, we review the use of bone marrow and cord blood in the hematopoietic stem cell transplant setting, and we describe the recent advances made in different medical fields using cells derived from cord blood and bone marrow. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Cord Blood, Bone Marrow, Hematopoietic Stem Cell Transplant, Immunotherapy, Regenerative Medicine </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Filippo Milano (<a href="mailto:fmilano@fredhutch.org">fmilano@fredhutch.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Filippo Milano </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work has been funded and supported by the Young Foundation. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Xue E and Milano F. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Xue E and Milano F. Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):26 (<a href="https://doi.org/10.12688/f1000research.20605.1" target=_blank>https://doi.org/10.12688/f1000research.20605.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 17 Jan 2020, <b>9</b>(F1000 Faculty Rev):26 (<a href="https://doi.org/10.12688/f1000research.20605.1" target=_blank>https://doi.org/10.12688/f1000research.20605.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 17 Jan 2020, <b>9</b>(F1000 Faculty Rev):26 (<a href="https://doi.org/10.12688/f1000research.20605.1" target=_blank>https://doi.org/10.12688/f1000research.20605.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d4405e151>Introduction</h2><p class="" id=d4405e154>The role of bone marrow (BM) as a source of hematopoietic stem cells (HSCs) has been well established since 1868, when Neumann and Bizzozero used BM to reconstitute the hematopoietic system of rabbits. However, it took almost a century (1957) to perform the first allogeneic BM transplant in humans<sup><a href="#ref-1">1</a></sup>. A few decades later, two other sources of HSCs were successfully used in the transplant setting: in 1981, mobilized peripheral blood (PB) was adopted for an autologous transplant in a patient with chronic myelogenous leukemia<sup><a href="#ref-2">2</a></sup>, and in 1988, cord blood (CB) cells were transplanted in a patient with Fanconi’s anemia<sup><a href="#ref-3">3</a></sup>. Since the first BM transplant, over a million HSC transplants (HSCTs) have been performed<sup><a href="#ref-4">4</a></sup>. The widening of clinical indications, the gradual extension of eligibility criteria, and the inclusion of older patients have led to a constant increase in the numbers of HSCTs performed. However, in the last decade, PB has gradually become the most used source for HSCT because of (1) its ease of collection, (2) donors are spared from general anesthesia, and (3) the faster and higher engraftment rate associated with its use (<a href="#f1">Figure 1</a>), making it the first choice in more than 70% of adult allogeneic HSCTs and in almost all cases of autologous HSCTs<sup><a href="#ref-5">5</a>–<a href="#ref-7">7</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/22656/ccc818d6-f1d6-4d73-8158-38575e74af84_figure1.gif"><img alt="ccc818d6-f1d6-4d73-8158-38575e74af84_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/22656/ccc818d6-f1d6-4d73-8158-38575e74af84_figure1.gif"></a><div class=caption><h3>Figure 1. Transplants by cell source from 1992 to 2018, unrelated donor transplants.</h3><p id=d4405e194>In the last decades, the number of hematopoietic stem cell transplants has progressively increased along with an expansion of peripheral blood as a source of stem cells. Data are reused from the National Marrow Donor Program (NMDP)/Be The Match with permission.</p></div></div><p class="" id=d4405e201>Despite being gradually confined to alternative hematopoietic graft sources, both CB and BM still retain unique biological and immunological properties and represent invaluable resources for the treatment of many medical conditions. In this review, we begin by addressing the pros and cons of CB and BM in the transplant setting. Next, we review their use in other fields such as immunotherapy and regenerative medicine.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4405e207>Cord blood</h2><div class=section><a name=d4405e210 class=n-a></a><h3 class=section-title>Allogeneic transplantation</h3><p class="" id=d4405e215>In recent decades, CB has emerged as a feasible alternative source of HSCs for pediatric and adult patients with hematological malignancies in need of an allogeneic transplant lacking a related or an unrelated donor (URD)<sup><a href="#ref-8">8</a></sup>. CB is a very attractive alternative source because of the increased level of HLA disparity that can be tolerated. This feature is of particular importance for patients from racial and ethnic minorities, for whom it can be difficult to find a URD<sup><a href="#ref-9">9</a></sup>. Indeed, in a recent National Marrow Donor Program study, an 8/8 HLA-matched URD was likely to be identified in 75% of white European patients, whereas a donor was identified in the URD registry in only around 20% and 35% of patients of African and Hispanic ancestry origin, respectively<sup><a href="#ref-9">9</a></sup>. Nowadays, CB has been used to transplant over 35,000 recipients and more than 730,000 CB units are stored and available worldwide in public banks<sup><a href="#ref-10">10</a></sup>.</p><p class="" id=d4405e234>Over the years, a number of retrospective studies have shown that CB transplantation (CBT) can yield disease-free survival (DFS) comparable to that of adult donor transplants in patients with hematologic malignancies<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>. In addition, many studies have confirmed low rates of malignant relapse after CBT compared with URD transplants, indicating that CB could be the preferred source for patients at high risk of relapse<sup><a href="#ref-13">13</a></sup>. CBT, when compared with the PB HSCT, also has the advantage of lower rates of chronic graft-versus-host disease (GvHD), which translates into lower long-term morbidity and mortality<sup><a href="#ref-12">12</a></sup>. The increased availability of CB units with a high cellular content, the use of double CB grafts, the direct intra-bone infusion of CB grafts to enhance the homing process, and numerous <i>ex vivo</i> expansion methods (major clinical trials using expanded CB units in HSCT are listed in <a href="#T1">Table 1</a>) have further increased the potential application of this graft source<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>. Recently, Cohen <i>et al</i>. reported on outcomes of 22 patients with high- and very high-risk hematological malignancies who received a single CB unit expanded by using the UM171 technology<sup><a href="#ref-16">16</a></sup>. No graft failure was observed, and 1-year incidences of overall survival (OS), chronic GvHD-free DFS, and transplant-related mortality (TRM) were 90%, 74%, and 5%, respectively<sup><a href="#ref-16">16</a></sup>. Given that the high rate of early post-transplant morbidity and the requirement for intensive early post-transplant management have markedly slowed down the adoption of CBT, the low rate of TRM reported in the latter study is of high clinical interest. Targeted care strategies and development of feasible and safe CB expansion platforms can potentially increase the utilization of CBT.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Summary of cord blood manipulation techniques in clinical trials.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d4405e288 class=n-a></a><thead><a name=d4405e290 class=n-a></a><tr><a name=d4405e292 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d4405e294 class=n-a></a>Approach</th><th align=left colspan=1 rowspan=1><a name=d4405e297 class=n-a></a>Median CD34<sup>+</sup> cell fold<br class=br>expansion (range)</th><th align=left colspan=1 rowspan=1><a name=d4405e305 class=n-a></a>Median infused<br class=br>(10<sup>6</sup>) CD34<sup>+</sup>/kg<br class=br>(range)</th><th align=left colspan=1 rowspan=1><a name=d4405e318 class=n-a></a>Median days to ANC<br class=br>engraftment (range)</th><th align=left colspan=1 rowspan=1><a name=d4405e323 class=n-a></a>Group</th></tr></thead><tbody><a name=d4405e328 class=n-a></a><tr><a name=d4405e330 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e332 class=n-a></a>Expansion</td><td colspan=1 rowspan=1><a name=d4405e335 class=n-a></a></td><td colspan=1 rowspan=1><a name=d4405e337 class=n-a></a></td><td colspan=1 rowspan=1><a name=d4405e339 class=n-a></a></td><td colspan=1 rowspan=1><a name=d4405e341 class=n-a></a></td></tr><tr><a name=d4405e344 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e346 class=n-a></a>Cytokines (e.g., SCF,<br class=br>TPO, and G-CSF)</td><td colspan=1 rowspan=1><a name=d4405e351 class=n-a></a>4 (0.1–20.0)</td><td colspan=1 rowspan=1><a name=d4405e354 class=n-a></a>0.104 (0.0097–3.11)</td><td colspan=1 rowspan=1><a name=d4405e357 class=n-a></a>28 days (15–49)</td><td colspan=1 rowspan=1><a name=d4405e360 class=n-a></a>Shpall <i>et al</i>.<sup><a href="#ref-27">27</a></sup></td></tr><tr><a name=d4405e370 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e372 class=n-a></a>Copper-chelation</td><td colspan=1 rowspan=1><a name=d4405e375 class=n-a></a>2.26 (0.67–19.2)</td><td colspan=1 rowspan=1><a name=d4405e378 class=n-a></a>0.15 (0.05–4.63)</td><td colspan=1 rowspan=1><a name=d4405e381 class=n-a></a>30 days (16–46)</td><td colspan=1 rowspan=1><a name=d4405e384 class=n-a></a>De Lima <i>et al</i>.<sup><a href="#ref-28">28</a></sup></td></tr><tr><a name=d4405e394 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e396 class=n-a></a>Notch-ligand</td><td colspan=1 rowspan=1><a name=d4405e399 class=n-a></a>164 (41–471)</td><td colspan=1 rowspan=1><a name=d4405e402 class=n-a></a>6 (0.93–13)</td><td colspan=1 rowspan=1><a name=d4405e405 class=n-a></a>16 days (7–34)</td><td colspan=1 rowspan=1><a name=d4405e408 class=n-a></a>Delaney <i>et al</i>.<sup><a href="#ref-29">29</a></sup></td></tr><tr><a name=d4405e418 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e420 class=n-a></a>MSC co-culture</td><td colspan=1 rowspan=1><a name=d4405e423 class=n-a></a>30.1 (0 – 137.8)</td><td colspan=1 rowspan=1><a name=d4405e426 class=n-a></a>1.81 (0.09–9.88)</td><td colspan=1 rowspan=1><a name=d4405e429 class=n-a></a>15 days (9–42)</td><td colspan=1 rowspan=1><a name=d4405e432 class=n-a></a>De Lima <i>et al</i>.<sup><a href="#ref-30">30</a></sup></td></tr><tr><a name=d4405e443 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e445 class=n-a></a>Nicotinamide</td><td colspan=1 rowspan=1><a name=d4405e448 class=n-a></a>72 (16–186)</td><td colspan=1 rowspan=1><a name=d4405e451 class=n-a></a>3.5 (0.9–18.3)</td><td colspan=1 rowspan=1><a name=d4405e454 class=n-a></a>13 days (7–26)</td><td colspan=1 rowspan=1><a name=d4405e457 class=n-a></a>Horwitz <i>et al</i>.<sup><a href="#ref-31">31</a></sup></td></tr><tr><a name=d4405e467 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e469 class=n-a></a>SR-1</td><td colspan=1 rowspan=1><a name=d4405e472 class=n-a></a>330 (67–848)</td><td colspan=1 rowspan=1><a name=d4405e475 class=n-a></a>17.5 (1.4–48.3)</td><td colspan=1 rowspan=1><a name=d4405e478 class=n-a></a>15 days (6–30)</td><td colspan=1 rowspan=1><a name=d4405e481 class=n-a></a>Wagner <i>et al</i>.<sup><a href="#ref-32">32</a></sup></td></tr><tr><a name=d4405e491 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e493 class=n-a></a>UM171</td><td colspan=1 rowspan=1><a name=d4405e496 class=n-a></a>28.1 (12.0–48.3)</td><td colspan=1 rowspan=1><a name=d4405e499 class=n-a></a>28.75 (7.9–54.6)</td><td colspan=1 rowspan=1><a name=d4405e502 class=n-a></a>18 days (12.5–20)</td><td colspan=1 rowspan=1><a name=d4405e505 class=n-a></a>Cohen <i>et al</i>.<sup><a href="#ref-16">16 </a></sup></td></tr><tr><a name=d4405e515 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e517 class=n-a></a>Homing</td><td colspan=1 rowspan=1><a name=d4405e520 class=n-a></a></td><td colspan=1 rowspan=1><a name=d4405e522 class=n-a></a></td><td colspan=1 rowspan=1><a name=d4405e524 class=n-a></a></td><td colspan=1 rowspan=1><a name=d4405e526 class=n-a></a></td></tr><tr><a name=d4405e529 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e531 class=n-a></a>CD26/DPP-4 inhibition</td><td colspan=1 rowspan=1><a name=d4405e534 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e537 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e540 class=n-a></a>21 days (13–50)</td><td colspan=1 rowspan=1><a name=d4405e543 class=n-a></a>Farag <i>et al</i>.<sup><a href="#ref-33">33</a></sup></td></tr><tr><a name=d4405e553 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e555 class=n-a></a>C3a priming</td><td colspan=1 rowspan=1><a name=d4405e558 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e561 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e564 class=n-a></a>7 days (6–26)</td><td colspan=1 rowspan=1><a name=d4405e567 class=n-a></a>Brunstein <i>et al</i>.<sup><a href="#ref-34">34</a></sup></td></tr><tr><a name=d4405e578 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e580 class=n-a></a>PGE2 exposure</td><td colspan=1 rowspan=1><a name=d4405e583 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e586 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e589 class=n-a></a>17.5 days (14–31)</td><td colspan=1 rowspan=1><a name=d4405e592 class=n-a></a>Cutler <i>et al</i>.<sup><a href="#ref-35">35</a></sup></td></tr><tr><a name=d4405e602 class=n-a></a><td colspan=1 rowspan=1><a name=d4405e604 class=n-a></a>Fucosylation</td><td colspan=1 rowspan=1><a name=d4405e607 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e610 class=n-a></a>-</td><td colspan=1 rowspan=1><a name=d4405e613 class=n-a></a>17 days (12–34)</td><td colspan=1 rowspan=1><a name=d4405e616 class=n-a></a>Popat <i>et al</i>.<sup><a href="#ref-36">36</a></sup></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d4405e630 class=n-a></a><p id=d4405e632> ANC, absolute neutrophil count; C3a, complement fragment 3; DPP-4, dipeptidyl-peptidase IV; G-CSF, granulocyte colony-stimulating factor; MSC, mesenchymal stromal cell; PGE2, prostaglandin 2; SCF, stem cell factor; SR-1, StemRegenin-1; TPO, thrombopoietin.</p></div></div></div></div><div class=section><a name=d4405e639 class=n-a></a><h3 class=section-title>Immunotherapy</h3><p class="" id=d4405e644>Unlike for HSCT, the use of CB cells for the development of adoptive therapies to treat post-transplant viral infections and malignant relapses has increased over the years. Virus-specific T (VST) cells are an appealing approach to prevent and treat viral reactivation in HSCT recipients, for whom long-duration antiviral treatments often cause unacceptable organ toxicity and virus resistance<sup><a href="#ref-17">17</a></sup>. Although CB T cells are virus-naïve<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>, Abraham <i>et al</i>. have recently reported on the successful generation and infusion of CB-derived VST cells directed against Epstein–Barr virus, adenovirus, and cytomegalovirus in CBT recipients as part of their antiviral prophylaxis or treatment or both<sup><a href="#ref-20">20</a>–<a href="#ref-22">22</a></sup>. The CB cells were obtained by separating an aliquot (20%) from the original CB graft, a process that did not delay or negatively impact neutrophil engraftment. Although the process was more time-consuming compared with VST cells generated from other sources, this approach was safe and feasible and showed efficacy in both preventing and treating end-organ viral infections<sup><a href="#ref-22">22</a></sup></p><p class="" id=d4405e671>Among strategies to manage post-transplant malignant relapse, the infusion of donor-derived lymphocytes is often performed to boost the graft-versus-tumor effect, but for CBT recipients this option is not routinely available. Case reports of re-infusion of lymphocytes collected directly from the CBT recipients after immune reconstitution, with <a href="#ref-23">23</a> or without <a href="#ref-24">24</a> <i>ex vivo</i> expansion, have been described, as has infusion of T cells previously collected from the original CB grafts and subsequently expanded <i>ex vivo</i><sup><a href="#ref-25">25</a></sup>. However, given the cost-effectiveness of these approaches, long-term safety and efficacy have to be carefully evaluated before they can enter the clinical routine.</p><p class="" id=d4405e689>Cellular immunotherapy, and more specifically autologous T cells genetically modified to express chimeric antigen receptor T (CAR-T) cells, has recently become the new frontier for the treatment for relapsed/refractory hematologic malignancies because of the ability to exert antitumoral cytotoxicity in an HLA-independent manner<sup><a href="#ref-26">26</a></sup>. The use of CAR-T cells has been explored mainly in the autologous setting, and very few studies have focused on the generation of allogeneic CAR-T cells. Given the naïve phenotype of CB-derived T cells as well as the large availability of CB units for the generation of cellular products along with the high <i>in vitro</i> proliferative capacity, CB represents a good and safe source of lymphocytes for the generation of allogeneic CAR-T cells. Indeed, several preclinical studies have investigated the use of CB for the generation of CB-derived T-cell lines possessing antileukemic activity by expressing CAR anti-CD19<sup><a href="#ref-37">37</a>–<a href="#ref-40">40</a></sup>. Of note is the recent generation of CB-derived chimeric antigen receptor natural killer (CAR-NK) cells: unlike CAR-T cells, CAR-NK cells can also recognize target cells in a CAR-independent way, thus maintaining an antitumor effect in case of CAR-specific antigen downregulation on tumor cells<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. To overcome the intrinsic short life span of CAR-NK cells, the incorporation of cytokine-encoding genes (for example, interleukin-15) has been successfully applied to this technology, allowing NK proliferation and survival<sup><a href="#ref-41">41</a></sup>. Third-party CAR-NK cells could be selected on the basis of killer-cell immunoglobulin-like receptor (KIR) mismatch between donor and recipient and used as an off-the-shelf product without risk of GvHD reaction; the goals would be to speed up the production and increase its feasibility. Clinical trials to determine the efficacy of CB-derived NK cells are ongoing.</p><p class="" id=d4405e717>Lastly, the use of CB-derived regulatory T (T-reg) cells is under investigation as part of prevention of GvHD. Brunstein <i>et al</i>. reported rates of acute and chronic GvHD of 9% and 0%, respectively, in 11 CBT recipients who received third-party CB T-reg cells on day +1 after transplant<sup><a href="#ref-43">43</a></sup>. In another study, five patients received an infusion of third-party CB-derived T-reg cells one day prior to PB SCT (n = 3) or double CBT (n = 2); the treatment was well tolerated, and four patients were off immune-suppression at the last follow-up evaluation<sup><a href="#ref-44">44</a></sup>. Further studies are needed to confirm these preliminary results.</p></div><div class=section><a name=d4405e732 class=n-a></a><h3 class=section-title>Regenerative medicine</h3><p class="" id=d4405e737>The core of regenerative medicine is based on the identification of cells with repopulating and/or growth factor–secreting potential placed on biomimetic scaffolds forming a matrix for tissue regeneration. For this scope, CB cells are promising because of their (1) proliferative potential compared with adult-derived cells, (2) low immunogenicity, (3) low risk of transmitting infections of latent viruses, and (4) ease of collection<sup><a href="#ref-45">45</a></sup>.</p><p class="" id=d4405e744>With this in mind, different types of CB-derived cells have been examined for their “regenerative” capability. Particular attention has been given to the use of CB-derived mesenchymal stromal cells (MSCs) and endothelial progenitor cells (EPCs). CB-derived MSCs are pluripotent cells that display immune-modulatory properties and have the potential to differentiate into multiple lineages of mesodermal origin (mainly to produce osteoblasts, chondroblasts, and adipocytes) but also non-traditional lineages (for example, cardiomyocytes and hepatocytes). In addition, MSCs are known for the ability to accelerate healing processes in brain injury, in both <i>in vitro</i> and <i>in vivo</i> models, by inducing a neuroprotective anti-inflammatory microenvironment and promoting neurogenesis and revascularization. In animal models of dilated cardiomyopathy and myocardial ischemia, CB-derived MSCs have been used to improve the cardiac function by decreasing and preventing cardiac fibrosis, ventricle changes, and cellular apoptosis<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. The use of CB-derived EPCs, like that of MSCs, has been extensively investigated in recent years; more specifically, endothelial colony-forming cells have shown the ability of homing into ischemic tissues, improving angiogenesis in preclinical models of ischemia<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>.</p><p class="" id=d4405e767>In the clinical setting, CB-based regenerative medicine has witnessed the greater innovations in the neurologic field, driven by the paucity of available treatments for progressive, non-reversible neurologic conditions. Sun <i>et al</i>. recently reported the results of a randomized placebo-controlled trial conducted in children affected by post-natal cerebral palsy; the authors reported an improvement in motor skill and white matter connectivity in patients who received a higher dose of autologous CB-derived total nucleated cells (TNCs) compared with patients who received either lower TNC dose or placebo<sup><a href="#ref-50">50</a></sup>. Similarly, Huang <i>et al</i>. reported a significant clinical improvement in 54 patients with cerebral palsy treated with allogeneic CB-derived MSCs<sup><a href="#ref-51">51</a></sup>. Encouraging results have also been achieved in autism spectrum disorders: repeated infusion of CB-derived MSCs were recently reported to be safe by Riordan <i>et al</i>. in a phase I trial, and behavioral improvement was reported in eight out of 15 evaluable patients<sup><a href="#ref-52">52</a></sup>. Furthermore, given the promising results in studies conducted on preclinical models<sup><a href="#ref-53">53</a>–<a href="#ref-55">55</a></sup>, the safety and therapeutic potential of CB-derived cells are under investigation in patients with neurodegenerative disorders, such as Parkinson’s disease or Alzheimer’s disease.</p><p class="" id=d4405e799>Ongoing phase I/II studies are exploring the role of CB-derived MSCs for the treatment of cardiac diseases. Of particular clinical interest is the observation that, in a randomized phase I/II clinical study, patients with heart failure who received an intravenous infusion of CB-derived MSCs had better post-ischemic myocardial remodeling and higher ventricular ejection fraction compared with the control group<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d4405e807>The safety and feasibility of CB-derived cells have been reported in several case series, but owing to the heterogeneity of these studies along with the lack of major comparative trials, their clinical efficacy still needs to be proven. Indeed, to date, none of these applications has been formally approved for clinical use.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4405e814>Bone marrow</h2><div class=section><a name=d4405e817 class=n-a></a><h3 class=section-title>Allogeneic transplantation</h3><p class="" id=d4405e822>For decades, BM has been the preferred source for HSCT. In the early ’90s, several studies demonstrated a direct correlation between higher number of HSCs infused and a reduction of early transplant-related mortality<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. This led to an increased use of granulocyte colony-stimulating factor (G-CSF)-primed PB, which in the last 15 years has gradually become the preferred graft source of HSCs<sup><a href="#ref-5">5</a></sup>. To date, aplastic anemia is the only disease for which the use of BM is mandatory because of the unacceptably high rate of chronic GvHD observed after PB HSCT<sup><a href="#ref-59">59</a>–<a href="#ref-61">61</a></sup>. BM also remains the preferred source of HSCs for pediatric patients (<a href="#f2">Figure 2</a>), for whom low cellularity is usually enough to ensure engraftment<sup><a href="#ref-62">62</a></sup>.</p><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/22656/ccc818d6-f1d6-4d73-8158-38575e74af84_figure2.gif"><img alt="ccc818d6-f1d6-4d73-8158-38575e74af84_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/22656/ccc818d6-f1d6-4d73-8158-38575e74af84_figure2.gif"></a><div class=caption><h3>Figure 2. Transplants by cell source for pediatric patients from 1992 to 2017, unrelated donor transplants.</h3><p id=d4405e860>In the pediatric population, defined as younger than 18 years, the most frequently used source is bone marrow. Data are reused from the National Marrow Donor Program (NMDP)/Be The Match with permission.</p></div></div><p class="" id=d4405e867>Many studies have compared BM and PB. In the first randomized clinical trial ever conducted in patients undergoing an HSCT with matched related donors, Bensinger <i>et al</i>. found a higher and faster rate of engraftment after PB, as compared with patients receiving BM, whereas no differences were observed for incidence of acute and chronic GvHD<sup><a href="#ref-63">63</a></sup>. The study suggested a better DFS in patients with advanced malignancies receiving PB<sup><a href="#ref-63">63</a></sup>. When focusing on long-term outcomes, Friedrichs <i>et al</i>. showed a higher incidence of chronic GvHD and longer need for immunosuppression therapy after HSCT using PB as source of HSCs<sup><a href="#ref-64">64</a></sup>. No differences were seen for OS and quality of life (for example, performance status and return to work) between PB and BM recipients<sup><a href="#ref-64">64</a></sup>. In 2012, the two graft sources were finally prospectively compared in the setting of URDs. The study showed a higher risk of graft failure but a lower rate of chronic GvHD among patients receiving BM; no significant differences were seen in OS between the two groups<sup><a href="#ref-6">6</a></sup>. The main finding of lower chronic GvHD led the authors to recommend the use of BM as the preferred source for HSCT, a recommendation that, however, has not been translated into clinical practice<sup><a href="#ref-6">6</a></sup>.</p><p class="" id=d4405e901>More recently, the use of BM has re-emerged in the setting of haploidentical transplants (that is, from half-matched related donors) that have been increasingly performed in the last decade<sup><a href="#ref-65">65</a></sup>. The original platform, described by Luznik <i>et al.</i>, using T cells-replete, haploidentical HSCT with post-transplant cyclophosphamide, included BM as the preferred HSC source<sup><a href="#ref-66">66</a></sup>; however, owing to the difficulty of obtaining BM, the same group explored the use of PB in the same setting, obtaining similar clinical results. As in URD transplants, these observations led to switching to PB as the preferred HSC source in the haploidentical setting as well<sup><a href="#ref-66">66</a>–<a href="#ref-71">71</a></sup>.</p><p class="" id=d4405e923>Although the use of BM is undoubtedly associated with a lower risk of chronic GvHD when compared with PB, the cumbersome process to obtain it and the slower time to engraftment have severely limited its application in the field of HSCT. To address the issue of slow engraftment and to reduce the rate of graft failure, some groups have investigated the use of a short course of G-CSF to stimulate BM before the harvest, documenting both an increase of progenitors and phenotypic changes in the lymphocyte component of the graft<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. These observations led to the hypothesis that BM priming would have further lowered the rate of GvHD while improving engraftment. However, neither retrospective nor prospective studies comparing G-CSF–primed BM versus either unmanipulated BM or PB showed any differences in OS<sup><a href="#ref-74">74</a>–<a href="#ref-77">77</a></sup>. Moreover, given that this procedure would expose the donors both to a drug administration and to a BM harvest, the enthusiasm for this approach has quickly faded.</p></div><div class=section><a name=d4405e941 class=n-a></a><h3 class=section-title>Immunotherapy</h3><p class="" id=d4405e946>The use of BM-derived MSCs has been widely investigated in the setting of severe, steroid-refractory GvHD. MSCs are capable of migrating into inflamed tissues affected by acute GvHD and actively inhibit T-cell proliferation, inducing a shift in the T cells toward a regulatory phenotype. Since the first report of successful use of MSCs in a case of refractory acute GvHD<sup><a href="#ref-78">78</a></sup>, several phase I/II studies have shown the safety and applicability of this approach. Although the heterogeneity of the studies using BM-derived MSCs has represented a major limitation for any definitive conclusions, the use of Remestemcel-L, an off-the-shelf BM-derived MSC product, has been approved for first-line treatment of acute GvHD and for the treatment of steroid-refractory acute GvHD. As first-line treatment, Remestemcel-L in combination with steroids led to 94% of overall responses, and 77% of those were complete<sup><a href="#ref-79">79</a></sup>. In the steroid-refractory GvHD setting, Remestemcel-L infusion, as single agent, led to a very promising 61% of overall response and significant improvement of survival<sup><a href="#ref-80">80</a></sup>. These results led to an open-label phase III trial that enrolled 55 children with steroid-refractory acute GvHD in 32 sites across the US, and 89% of patients had the most severe form (ClinicalTrials.gov Identifier: NCT02336230). The trial met the primary endpoint of day-28 overall response rate (69% versus 45% historical control rate)<sup><a href="#ref-81">81</a></sup>. Based on these results, the use Remestemcel-L is under evaluation by the US Food and Drug Administration as the first approved treatment of steroid-refractory acute GvHD.</p></div><div class=section><a name=d4405e966 class=n-a></a><h3 class=section-title>Regenerative medicine</h3><p class="" id=d4405e971>BM cells are as valuable as CB cells as a source for the regenerative medicine field<sup><a href="#ref-82">82</a></sup>. Indeed, autologous and allogeneic BM aspirates, BM concentrates, and BM-derived cells have been extensively investigated to treat musculoskeletal conditions, especially for bone and cartilage damage such as osteoarthritis, bone fractures, or congenital skeletal malformations<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup>.</p><p class="" id=d4405e985>Besides musculoskeletal conditions, BM-derived cells, such as EPCs, MSCs, and mononuclear cells, have been used to treat cardiac, endocrine (with a special focus on diabetes mellitus), and neurologic disorders. Whereas early phase I and II clinical trials have shown promising outcomes in patients receiving intracardiac injection of BM-derived cells after myocardial infarction, randomized placebo-controlled phase III studies have shown contradictory results in terms of overall clinical impact<sup><a href="#ref-85">85</a>–<a href="#ref-87">87</a></sup>.</p><p class="" id=d4405e995>BM-derived MSCs have been adopted for treating diabetes, showing the potential to improve the glycemic curve in preclinical models by differentiating <i>in vitro</i> into insulin-producing cells and by exerting a protective role against immune-mediated destruction of pancreatic beta cells in type 1 diabetes<sup><a href="#ref-88">88</a>,<a href="#ref-89">89</a></sup>. Within a cohort of 30 patients with type 2 diabetes requiring multiple oral anti-hyperglycemic drugs plus high-dose insulin, Bhansali <i>et al</i>. showed a significant reduction in insulin requirement after the infusion of BM-derived MSCs compared with patients receiving placebo<sup><a href="#ref-90">90</a></sup>.</p><p class="" id=d4405e1015>More recently, several early phase clinical trials have investigated the role of BM-derived MSCs and mononuclear cells for the treatment of neurological conditions, including refractory multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, and cerebrovascular attacks<sup><a href="#ref-91">91</a>–<a href="#ref-95">95</a></sup>. In all cases, the treatment has been shown to be safe and feasible, although the clinical efficacy remains controversial.</p><p class="" id=d4405e1026>Lastly, increasing interest has been raised around BM-derived MSC-secreted exosomes, extracellular nucleic acid-containing (for example, microRNA) and protein-containing vesicles that play a significant role in immune response and signal transduction. In preclinical studies, the administration of cell-free MSC-derived exosomes has been shown to improve cellular protection and regeneration in animal models of osteoporosis, bone fracture, optic nerve injury, traumatic brain injury, necrotizing enterocolitis, and other morbid conditions<sup><a href="#ref-96">96</a>–<a href="#ref-100">100</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4405e1040>Conclusions</h2><p class="" id=d4405e1043>Much has been learned since the first HSCT performed in the late ’50s. The use of HSCT for patients with hematological disease continues to increase because of a constant decrease in transplant-related morbidity and mortality and a consequent improvement of clinical outcomes. Owing to the growing enthusiasm for PB as a source of stem cells, the use of CB and BM has decreased in recent years: according to the National Marrow Donor Program, CB and BM are being adopted in only 16% and 19% of all HSCTs, respectively. Although BM and CB transplantations are established practices for the treatment of hematological malignancies in adult and pediatric patients, the high transplant-related mortality due to delayed hematopoietic recovery (CB) and the difficulty of its acquisition (BM) have helped slow down the widespread adoption of both. There are several ongoing challenges to expand the use of CB. Although a number of methods to increase engraftment speed have been successfully investigated, the cost of CB grafts and the lack of substantial improvement in early post-transplant supportive care represent major unmet issues. For BM, the main limitation remains related to the difficulty and the invasiveness of its collection. Despite the undeniable advantage of a lower risk of chronic GvHD and consequently of a better quality of life, its use has not increased.</p><p class="" id=d4405e1046>In recent years, we have learned more about the properties of CB and BM as well as their application to regenerative medicine and immunotherapy. Although there have not been major safety concerns regarding the use of CB-derived and BM-derived products, most of the clinical trials have been conducted on very small or heterogeneous cohorts (or both), using different cell populations, cell doses, and routes of administration. Randomized placebo-controlled studies are needed to better determine the efficacy of these approaches before translating them into standard clinical practice. With the development of new technologies allowing better characterization, selection, and expansion of different cell populations from CB and BM, we could envision a progressively higher utilization of these cell sources, not only in the transplant field but also in many other fields of medicine.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4405e1052>Abbreviations</h2><p class="" id=d4405e1055>BM, bone marrow; CAR-NK cells, chimeric antigen receptor natural killer cells; CAR-T cells, chimeric antigen receptor T cells; CB, cord blood; CBT cord blood transplant; DFS, disease-free survival; EPC, endothelial progenitor cell; G-CSF, granulocyte colony-stimulating factor; GvHD, graft-versus-host disease; HSC, hematopoietic stem cell; HSCT, hematopoietic stem cell transplant; MSC, mesenchymal stromal cell; NK cells, natural killer cells; OS, overall survival; PB, peripheral blood; TNC, total nucleated cell; T-reg, regulatory T cell; TRM, transplant-related mortality; URD, unrelated donor; VST, virus-specific T cell.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d4405e1062 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d5088>References</h2><div class="section ref-list"><a name=d4405e1062 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d4405e1069 class=n-a></a>Thomas ED, Lochte HL Jr, Lu WC, <i> et al.</i>: Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. <i>N Engl J Med.</i> 1957; <b>257</b>(11): 491–496. <a target=xrefwindow id=d4405e1080 href="http://www.ncbi.nlm.nih.gov/pubmed/13464965">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1083 href="https://doi.org/10.1056/NEJM195709122571102">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d4405e1092 class=n-a></a>Goldman JM, Johnson SA, Catovsky D, <i> et al.</i>: Autografting for chronic granulocytic leukemia. <i>N Engl J Med.</i> 1981; <b>305</b>(12): 700. <a target=xrefwindow id=d4405e1103 href="http://www.ncbi.nlm.nih.gov/pubmed/6943426">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1106 href="https://doi.org/ 10.1056/NEJM198109173051215">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d4405e1115 class=n-a></a>Gluckman E, Broxmeyer HA, Auerbach AD, <i> et al.</i>: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. <i>N Engl J Med.</i> 1989; <b>321</b>(17): 1174–1178. <a target=xrefwindow id=d4405e1126 href="http://www.ncbi.nlm.nih.gov/pubmed/2571931">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1129 href="https://doi.org/10.1056/NEJM198910263211707">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726040527"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1138 class=n-a></a>Gratwohl A, Pasquini MC, Aljurf M, <i> et al.</i>: One million haemopoietic stem-cell transplants: a retrospective observational study. <i>Lancet Haematol.</i> 2015; <b>2</b>(3): e91–100. <a target=xrefwindow id=d4405e1149 href="http://www.ncbi.nlm.nih.gov/pubmed/26687803">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1152 href="https://doi.org/10.1016/S2352-3026(15)00028-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726040527">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d4405e1165 class=n-a></a>Körbling M, Freireich EJ: Twenty-five years of peripheral blood stem cell transplantation. <i>Blood.</i> 2011; <b>117</b>(24): 6411–6416. <a target=xrefwindow id=d4405e1173 href="http://www.ncbi.nlm.nih.gov/pubmed/21460243">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1176 href="https://doi.org/10.1182/blood-2010-12-322214">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962290"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1186 class=n-a></a>Anasetti C, Logan BR, Lee SJ, <i> et al.</i>: Peripheral-blood stem cells versus bone marrow from unrelated donors. <i>N Engl J Med.</i> 2012; <b>367</b>(16): 1487–1496. <a target=xrefwindow id=d4405e1197 href="http://www.ncbi.nlm.nih.gov/pubmed/23075175">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1200 href="https://doi.org/10.1056/NEJMoa1203517">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1204 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3816375">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962290">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d4405e1217 class=n-a></a>Passweg JR, Baldomero H, Bader P, <i> et al.</i>: Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. <i>Bone Marrow Transplant.</i> 2016; <b>51</b>(6): 786–792. <a target=xrefwindow id=d4405e1228 href="http://www.ncbi.nlm.nih.gov/pubmed/26901709">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1231 href="https://doi.org/10.1038/bmt.2016.20">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1235 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4895175">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d4405e1244 class=n-a></a>Barker JN, Byam CE, Kernan NA, <i> et al.</i>: Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. <i>Biol Blood Marrow Transplant.</i> 2010; <b>16</b>(11): 1541–1548. <a target=xrefwindow id=d4405e1255 href="http://www.ncbi.nlm.nih.gov/pubmed/20800103">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1258 href="https://doi.org/10.1016/j.bbmt.2010.08.011">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1262 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3685152">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718503884"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1271 class=n-a></a>Gragert L, Eapen M, Williams E, <i> et al.</i>: HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. <i>N Engl J Med.</i> 2014; <b>371</b>(4): 339–348. <a target=xrefwindow id=d4405e1282 href="http://www.ncbi.nlm.nih.gov/pubmed/25054717">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1285 href="https://doi.org/10.1056/NEJMsa1311707">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1289 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5965695">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718503884">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733261506"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1302 class=n-a></a>Dessels C, Alessandrini M, Pepper MS: Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape. <i>Stem Cells Transl Med.</i> 2018; <b>7</b>(9): 643–650. <a target=xrefwindow id=d4405e1310 href="http://www.ncbi.nlm.nih.gov/pubmed/29777574">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1313 href="https://doi.org/10.1002/sctm.17-0244">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1316 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6127225">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733261506">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4855960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1329 class=n-a></a>Brunstein CG, Gutman JA, Weisdorf DJ, <i> et al.</i>: Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. <i>Blood.</i> 2010; <b>116</b>(22): 4693–4699. <a target=xrefwindow id=d4405e1340 href="http://www.ncbi.nlm.nih.gov/pubmed/20686119">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1343 href="https://doi.org/10.1182/blood-2010-05-285304">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1347 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2996124">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4855960">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d4405e1361 class=n-a></a>Ruggeri A, Labopin M, Sanz G, <i> et al.</i>: Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. <i>Leukemia.</i> 2015; <b>29</b>(9): 1891–1900. <a target=xrefwindow id=d4405e1372 href="http://www.ncbi.nlm.nih.gov/pubmed/25882700">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1375 href="https://doi.org/10.1038/leu.2015.98">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d4405e1384 class=n-a></a>Milano F, Gooley T, Wood B, <i> et al.</i>: Cord-Blood Transplantation in Patients with Minimal Residual Disease. <i>N Engl J Med.</i> 2016; <b>375</b>(10): 944–953. <a target=xrefwindow id=d4405e1395 href="http://www.ncbi.nlm.nih.gov/pubmed/27602666">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1398 href="https://doi.org/10.1056/NEJMoa1602074">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1402 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5513721">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d4405e1411 class=n-a></a>Barker JN, Weisdorf DJ, DeFor TE, <i> et al.</i>: Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. <i>Blood.</i> 2005; <b>105</b>(3): 1343–1347. <a target=xrefwindow id=d4405e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/15466923">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1425 href="https://doi.org/10.1182/blood-2004-07-2717">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1121799"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1434 class=n-a></a>Frassoni F, Gualandi F, Podestà M, <i> et al.</i>: Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. <i>Lancet Oncol.</i> 2008; <b>9</b>(9): 831–839. <a target=xrefwindow id=d4405e1445 href="http://www.ncbi.nlm.nih.gov/pubmed/18693069">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1448 href="https://doi.org/10.1016/S1470-2045(08)70180-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1121799">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736914375"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1461 class=n-a></a>Cohen S, Roy J, Lachance S, <i> et al.</i>: Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study. <i>Lancet Haematol.</i> 2019; pii: S2352-3026(19)30202-9. <a target=xrefwindow id=d4405e1469 href="http://www.ncbi.nlm.nih.gov/pubmed/31704264">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1472 href="https://doi.org/10.1016/S2352-3026(19)30202-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736914375">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d4405e1485 class=n-a></a>Bollard CM, Heslop HE: T cells for viral infections after allogeneic hematopoietic stem cell transplant. <i>Blood.</i> 2016; <b>127</b>(26): 3331–3340. <a target=xrefwindow id=d4405e1493 href="http://www.ncbi.nlm.nih.gov/pubmed/27207801">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1496 href="https://doi.org/10.1182/blood-2016-01-628982">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1499 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4929925">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d4405e1509 class=n-a></a>Sun Q, Burton RL, Pollok KE, <i> et al.</i>: CD4<sup>+</sup> Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. <i>Cell Immunol.</i> 1999; <b>195</b>(2): 81–88. <a target=xrefwindow id=d4405e1523 href="http://www.ncbi.nlm.nih.gov/pubmed/10448007">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1527 href="https://doi.org/10.1006/cimm.1999.1514">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d4405e1536 class=n-a></a>Park KD, Marti L, Kurtzberg J, <i> et al.</i>: <i>In vitro</i> priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes. <i>Blood.</i> 2006; <b>108</b>(5): 1770–1773. <a target=xrefwindow id=d4405e1550 href="http://www.ncbi.nlm.nih.gov/pubmed/16675712">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1554 href="https://doi.org/10.1182/blood-2005-10-006536">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1895512">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d4405e1566 class=n-a></a>Hanley PJ, Cruz CR, Savoldo B, <i> et al.</i>: Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. <i>Blood.</i> 2009; <b>114</b>(9): 1958–1967. <a target=xrefwindow id=d4405e1577 href="http://www.ncbi.nlm.nih.gov/pubmed/19443656">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1580 href="https://doi.org/10.1182/blood-2009-03-213256">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1584 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2738578">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729972437"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1593 class=n-a></a>Dave H, Luo M, Blaney JW, <i> et al.</i>: Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood. <i>Mol Ther Methods Clin Dev.</i> 2017; <b>5</b>: 13–21. <a target=xrefwindow id=d4405e1604 href="http://www.ncbi.nlm.nih.gov/pubmed/28480300">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1607 href="https://doi.org/10.1016/j.omtm.2017.02.001">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1611 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5415312">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729972437">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736403534"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1624 class=n-a></a>Abraham AA, John TD, Keller MD, <i> et al.</i>: Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. <i>Blood Adv.</i> 2019; <b>3</b>(14): 2057–68. <a target=xrefwindow id=d4405e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/31292125">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1638 href="https://doi.org/10.1182/bloodadvances.2019000201">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1642 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6650740">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736403534">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d4405e1655 class=n-a></a>Muto T, Ohwada C, Yamazaki A, <i> et al.</i>: Long-term complete remission by infusion of <i>ex vivo</i>-expanded donor-derived CD4<sup>+</sup> lymphocytes for treating an early relapse of Hodgkin lymphoma after cord blood transplantation. <i>Leuk Lymphoma.</i> 2016; <b>57</b>(1): 230–232. <a target=xrefwindow id=d4405e1673 href="http://www.ncbi.nlm.nih.gov/pubmed/25962436">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1676 href="https://doi.org/10.3109/10428194.2015.1041390">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d4405e1686 class=n-a></a>Lamure S, Delage J, Vincent L, <i> et al.</i>: Infusion of <i>in vivo</i> expanded cord blood lymphocytes: A new strategy to control residual disease? <i>Curr Res Transl Med.</i> 2018; <b>66</b>(3): 91–93. <a target=xrefwindow id=d4405e1700 href="http://www.ncbi.nlm.nih.gov/pubmed/29525419">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1704 href="https://doi.org/10.1016/j.retram.2018.02.003">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d4405e1713 class=n-a></a>Berglund S, Gertow J, Uhlin M, <i> et al.</i>: Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation. <i>Cytotherapy.</i> 2014; <b>16</b>(11): 1528–1536. <a target=xrefwindow id=d4405e1724 href="http://www.ncbi.nlm.nih.gov/pubmed/25231890">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1727 href="https://doi.org/10.1016/j.jcyt.2014.08.001">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733574769"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1736 class=n-a></a>June CH, Sadelain M: Chimeric Antigen Receptor Therapy. <i>N Engl J Med.</i> 2018; <b>379</b>(1): 64–73. <a target=xrefwindow id=d4405e1744 href="http://www.ncbi.nlm.nih.gov/pubmed/29972754">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1747 href="https://doi.org/10.1056/NEJMra1706169">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733574769">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d4405e1760 class=n-a></a>Shpall EJ, Quinones R, Giller R, <i> et al.</i>: Transplantation of <i>ex vivo</i> expanded cord blood. <i>Biol Blood Marrow Transplant.</i> 2002; <b>8</b>(7): 368–376. <a target=xrefwindow id=d4405e1774 href="http://www.ncbi.nlm.nih.gov/pubmed/12171483">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1778 href="https://doi.org/10.1053/bbmt.2002.v8.pm12171483">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d4405e1787 class=n-a></a>de Lima M, McMannis J, Gee A, <i> et al.</i>: Transplantation of <i>ex vivo</i> expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. <i>Bone Marrow Transplant.</i> 2008; <b>41</b>(9): 771–778. <a target=xrefwindow id=d4405e1801 href="http://www.ncbi.nlm.nih.gov/pubmed/18209724">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1805 href="https://doi.org/10.1038/sj.bmt.1705979">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1808 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4086223">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1821956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1817 class=n-a></a>Delaney C, Heimfeld S, Brashem-Stein C, <i> et al.</i>: Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. <i>Nat Med.</i> 2010; <b>16</b>(2): 232–236. <a target=xrefwindow id=d4405e1828 href="http://www.ncbi.nlm.nih.gov/pubmed/20081862">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1831 href="https://doi.org/10.1038/nm.2080">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1835 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2819359">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1821956">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969436"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1849 class=n-a></a>de Lima M, McNiece I, Robinson SN, <i> et al.</i>: Cord-blood engraftment with <i>ex vivo</i> mesenchymal-cell coculture. <i>N Engl J Med.</i> 2012; <b>367</b>(24): 2305–2315. <a target=xrefwindow id=d4405e1863 href="http://www.ncbi.nlm.nih.gov/pubmed/23234514">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1867 href="https://doi.org/10.1056/NEJMoa1207285">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1870 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3805360">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969436">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d4405e1882 class=n-a></a>Horwitz ME, Chao NJ, Rizzieri DA, <i> et al.</i>: Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. <i>J Clin Invest.</i> 2014; <b>124</b>(7): 3121–3128. <a target=xrefwindow id=d4405e1893 href="http://www.ncbi.nlm.nih.gov/pubmed/24911148">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1896 href="https://doi.org/10.1172/JCI74556">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1900 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4071379">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726014489"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1909 class=n-a></a>Wagner JE Jr, Brunstein CG, Boitano AE, <i> et al.</i>: Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft. <i>Cell Stem Cell.</i> 2016; <b>18</b>(1): 144–155. <a target=xrefwindow id=d4405e1920 href="http://www.ncbi.nlm.nih.gov/pubmed/26669897">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1923 href="https://doi.org/10.1016/j.stem.2015.10.004">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1927 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4881386">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726014489">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d4405e1940 class=n-a></a>Farag SS, Srivastava S, Messina-Graham S, <i> et al.</i>: <i>In vivo</i> DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. <i>Stem Cells Dev.</i> 2013; <b>22</b>(7): 1007–1015. <a target=xrefwindow id=d4405e1954 href="http://www.ncbi.nlm.nih.gov/pubmed/23270493">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1958 href="https://doi.org/10.1089/scd.2012.0636">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1961 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3607909">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d4405e1970 class=n-a></a>Brunstein CG, McKenna DH, DeFor TE, <i> et al.</i>: Complement fragment 3a priming of umbilical cord blood progenitors: safety profile. <i>Biol Blood Marrow Transplant.</i> 2013; <b>19</b>(10): 1474–1479. <a target=xrefwindow id=d4405e1981 href="http://www.ncbi.nlm.nih.gov/pubmed/23892047">PubMed Abstract </a> | <a target=xrefwindow id=d4405e1984 href="https://doi.org/10.1016/j.bbmt.2013.07.016">Publisher Full Text </a> | <a target=xrefwindow id=d4405e1988 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4638116">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718095492"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e1997 class=n-a></a>Cutler C, Multani P, Robbins D, <i> et al.</i>: Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. <i>Blood.</i> 2013; <b>122</b>(17): 3074–3081. <a target=xrefwindow id=d4405e2008 href="http://www.ncbi.nlm.nih.gov/pubmed/23996087">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2011 href="https://doi.org/10.1182/blood-2013-05-503177">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2015 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3811179">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718095492">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725392281"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2028 class=n-a></a>Popat U, Mehta RS, Rezvani K, <i> et al.</i>: Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. <i>Blood.</i> 2015; <b>125</b>(19): 2885–2892. <a target=xrefwindow id=d4405e2039 href="http://www.ncbi.nlm.nih.gov/pubmed/25778529">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2042 href="https://doi.org/10.1182/blood-2015-01-607366">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2046 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4424412">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725392281">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d4405e2059 class=n-a></a>Serrano LM, Pfeiffer T, Olivares S, <i> et al.</i>: Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy. <i>Blood.</i> 2006; <b>107</b>(7): 2643–2652. <a target=xrefwindow id=d4405e2070 href="http://www.ncbi.nlm.nih.gov/pubmed/16352804">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2073 href="https://doi.org/10.1182/blood-2005-09-3904">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2077 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1895371">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d4405e2086 class=n-a></a>Huang X, Guo H, Kang J, <i> et al.</i>: <i>Sleeping Beauty</i> transposon-mediated engineering of human primary T cells for therapy of CD19<sup>+</sup> lymphoid malignancies. <i>Mol Ther.</i> 2008; <b>16</b>(3): 580–589. <a target=xrefwindow id=d4405e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/18227839">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2107 href="https://doi.org/10.1038/sj.mt.6300404">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2110 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4539139">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d4405e2119 class=n-a></a>Pegram HJ, Purdon TJ, van Leeuwen DG, <i> et al.</i>: IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. <i>Leukemia.</i> 2015; <b>29</b>(2): 415–422. <a target=xrefwindow id=d4405e2130 href="http://www.ncbi.nlm.nih.gov/pubmed/25005243">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2133 href="https://doi.org/10.1038/leu.2014.215">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2137 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5189717">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d4405e2146 class=n-a></a>Dolnikov A, Shen S, Klamer G, <i> et al.</i>: Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia. <i>Exp Hematol.</i> 2015; <b>43</b>(12): 1001–1014.e1005. <a target=xrefwindow id=d4405e2157 href="http://www.ncbi.nlm.nih.gov/pubmed/26384559">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2160 href="https://doi.org/10.1016/j.exphem.2015.08.006">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d4405e2169 class=n-a></a>Liu E, Tong Y, Dotti G, <i> et al.</i>: Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. <i>Leukemia.</i> 2018; <b>32</b>(2): 520–531. <a target=xrefwindow id=d4405e2180 href="http://www.ncbi.nlm.nih.gov/pubmed/28725044">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2183 href="https://doi.org/10.1038/leu.2017.226">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2187 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6063081">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d4405e2197 class=n-a></a>Shah N, Martin-Antonio B, Yang H, <i> et al.</i>: Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. <i>PLoS One.</i> 2013; <b>8</b>(10): e76781. <a target=xrefwindow id=d4405e2208 href="http://www.ncbi.nlm.nih.gov/pubmed/24204673">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2211 href="https://doi.org/10.1371/journal.pone.0076781">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2215 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3800010">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725934129"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2224 class=n-a></a>Brunstein CG, Miller JS, McKenna DH, <i> et al.</i>: Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. <i>Blood.</i> 2016; <b>127</b>(8): 1044–1051. <a target=xrefwindow id=d4405e2235 href="http://www.ncbi.nlm.nih.gov/pubmed/26563133">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2238 href="https://doi.org/10.1182/blood-2015-06-653667">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2242 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4768428">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725934129">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d4405e2255 class=n-a></a>Kellner JN, Delemarre EM, Yvon E, <i> et al.</i>: Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution. <i>Oncotarget.</i> 2018; <b>9</b>(86): 35611–35622. <a target=xrefwindow id=d4405e2266 href="http://www.ncbi.nlm.nih.gov/pubmed/30479692">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2269 href="https://doi.org/10.18632/oncotarget.26242">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2273 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6235025">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d4405e2282 class=n-a></a>van de Ven C, Collins D, Bradley MB, <i> et al.</i>: The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. <i>Exp Hematol.</i> 2007; <b>35</b>(12): 1753–1765. <a target=xrefwindow id=d4405e2293 href="http://www.ncbi.nlm.nih.gov/pubmed/17949892">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2296 href="https://doi.org/10.1016/j.exphem.2007.08.017">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727252448"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2305 class=n-a></a>Mao C, Hou X, Wang B, <i> et al.</i>: Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats. <i>Stem Cell Res Ther.</i> 2017; <b>8</b>(1): 18. <a target=xrefwindow id=d4405e2316 href="http://www.ncbi.nlm.nih.gov/pubmed/28129792">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2319 href="https://doi.org/10.1186/s13287-017-0472-y">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2323 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5273808">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727252448">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d4405e2336 class=n-a></a>Liu CB, Huang H, Sun P, <i> et al.</i>: Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia. <i>Stem Cells Transl Med.</i> 2016; <b>5</b>(8): 1004–13. <a target=xrefwindow id=d4405e2347 href="http://www.ncbi.nlm.nih.gov/pubmed/27334487">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2350 href="https://doi.org/10.5966/sctm.2015-0298">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2354 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4954453">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d4405e2364 class=n-a></a>Alphonse RS, Vadivel A, Fung M, <i> et al.</i>: Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth. <i>Circulation.</i> 2014; <b>129</b>(21): 2144–57. <a target=xrefwindow id=d4405e2375 href="http://www.ncbi.nlm.nih.gov/pubmed/24710033">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2378 href="https://doi.org/10.1161/CIRCULATIONAHA.114.009124">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2382 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4162516">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d4405e2391 class=n-a></a>Palii CG, Vulesevic B, Fraineau S, <i> et al.</i>: Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes. <i>Cell Stem Cell.</i> 2014; <b>14</b>(5): 644–57. <a target=xrefwindow id=d4405e2402 href="http://www.ncbi.nlm.nih.gov/pubmed/24792117">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2405 href="https://doi.org/10.1016/j.stem.2014.03.003">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732046530"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2414 class=n-a></a>Sun JM, Song AW, Case LE, <i> et al.</i>: Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial. <i>Stem Cells Transl Med.</i> 2017; <b>6</b>(12): 2071–2078. <a target=xrefwindow id=d4405e2425 href="http://www.ncbi.nlm.nih.gov/pubmed/29080265">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2428 href="https://doi.org/10.1002/sctm.17-0102">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2432 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5702515">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732046530">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733031048"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2445 class=n-a></a>Huang L, Zhang C, Gu J, <i> et al.</i>: A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy. <i>Cell Transplant.</i> 2018; <b>27</b>(2): 325–334. <a target=xrefwindow id=d4405e2456 href="http://www.ncbi.nlm.nih.gov/pubmed/29637820">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2459 href="https://doi.org/10.1177/0963689717729379">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2463 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5898688">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733031048">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735978483"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2476 class=n-a></a>Riordan NH, Hincapié ML, Morales I, <i> et al.</i>: Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels. <i>Stem Cells Transl Med.</i> 2019; <b>8</b>(10): 1008–1016. <a target=xrefwindow id=d4405e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/31187597">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2490 href="https://doi.org/10.1002/sctm.19-0010">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6766688">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735978483">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d4405e2507 class=n-a></a>Shetty P, Thakur AM, Viswanathan C: Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson’s disease rodent model. <i>Cell Biol Int.</i> 2013; <b>37</b>(2): 167–80. <a target=xrefwindow id=d4405e2515 href="http://www.ncbi.nlm.nih.gov/pubmed/23339105">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2518 href="https://doi.org/10.1002/cbin.10029">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d4405e2528 class=n-a></a>Boutajangout A, Noorwali A, Atta H, <i> et al.</i>: Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease. <i>Curr Alzheimer Res.</i> 2017; <b>14</b>(1): 104–111. <a target=xrefwindow id=d4405e2539 href="http://www.ncbi.nlm.nih.gov/pubmed/27719629">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2542 href="https://doi.org/10.2174/1567205013666161004151416">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2546 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5241019">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727138175"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2555 class=n-a></a>Cui Y, Ma S, Zhang C, <i> et al.</i>: Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer's disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis. <i>Behav Brain Res.</i> 2017; <b>320</b>: 291–301. <a target=xrefwindow id=d4405e2566 href="http://www.ncbi.nlm.nih.gov/pubmed/28007537">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2569 href="https://doi.org/10.1016/j.bbr.2016.12.021">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727138175">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731737234"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2582 class=n-a></a>Bartolucci J, Verdugo FJ, Gonzalez PL, <i> et al.</i>: Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]). <i>Circ Res.</i> 2017; <b>121</b>(10): 1192–1204. <a target=xrefwindow id=d4405e2593 href="http://www.ncbi.nlm.nih.gov/pubmed/28974553">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2596 href="https://doi.org/10.1161/CIRCRESAHA.117.310712">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2600 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6372053">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731737234">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d4405e2613 class=n-a></a>Korbling M, Przepiorka D, Huh YO, <i> et al.</i>: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. <i>Blood.</i> 1995; <b>85</b>(6): 1659–1665. <a target=xrefwindow id=d4405e2624 href="http://www.ncbi.nlm.nih.gov/pubmed/7888684">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2627 href="https://doi.org/10.1016/s0887-7963(05)80085-9">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d4405e2636 class=n-a></a>Bacigalupo A, Van Lint MT, Valbonesi M, <i> et al.</i>: Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. <i>Blood.</i> 1996; <b>88</b>(1): 353–357. <a target=xrefwindow id=d4405e2647 href="http://www.ncbi.nlm.nih.gov/pubmed/8704195">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2650 href="https://doi.org/10.1182/blood.V88.1.353.bloodjournal881353">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d4405e2659 class=n-a></a>Bacigalupo A, Socie G, Schrezenmeier H, <i> et al.</i>: Bone marrow <i>versus</i> peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. <i>Haematologica.</i> 2012; <b>97</b>(8): 1142–1148. <a target=xrefwindow id=d4405e2673 href="http://www.ncbi.nlm.nih.gov/pubmed/22315497">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2677 href="https://doi.org/10.3324/haematol.2011.054841">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3409810">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727215403"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2690 class=n-a></a>Bacigalupo A: How I treat acquired aplastic anemia. <i>Blood.</i> 2017; <b>129</b>(11): 1428–1436. <a target=xrefwindow id=d4405e2698 href="http://www.ncbi.nlm.nih.gov/pubmed/28096088">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2701 href="https://doi.org/10.1182/blood-2016-08-693481">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727215403">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d4405e2714 class=n-a></a>Schrezenmeier H, Passweg JR, Marsh JC, <i> et al.</i>: Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. <i>Blood.</i> 2007; <b>110</b>(4): 1397–1400. <a target=xrefwindow id=d4405e2725 href="http://www.ncbi.nlm.nih.gov/pubmed/17475907">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2728 href="https://doi.org/10.1182/blood-2007-03-081596">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2732 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1939910">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737150139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2741 class=n-a></a>Simonin M, Dalissier A, Labopin M, <i> et al.</i>: More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party. <i>Bone Marrow Transplant.</i> 2017; <b>52</b>(7): 1071–1073. <a target=xrefwindow id=d4405e2752 href="http://www.ncbi.nlm.nih.gov/pubmed/28394370">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2755 href="https://doi.org/10.1038/bmt.2017.66">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737150139">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d4405e2768 class=n-a></a>Bensinger WI, Martin PJ, Storer B, <i> et al.</i>: Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. <i>N Engl J Med.</i> 2001; <b>344</b>(3): 175–181. <a target=xrefwindow id=d4405e2779 href="http://www.ncbi.nlm.nih.gov/pubmed/11172139">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2782 href="https://doi.org/10.1056/NEJM200101183440303">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720489124"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2791 class=n-a></a>Friedrichs B, Tichelli A, Bacigalupo A, <i> et al.</i>: Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. <i>Lancet Oncol.</i> 2010; <b>11</b>(4): 331–338. <a target=xrefwindow id=d4405e2802 href="http://www.ncbi.nlm.nih.gov/pubmed/20117965">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2805 href="https://doi.org/10.1016/S1470-2045(09)70352-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720489124">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d4405e2818 class=n-a></a>Passweg JR, Baldomero H, Bader P, <i> et al.</i>: Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. <i>Bone Marrow Transplant.</i> 2017; <b>52</b>(6): 811–817. <a target=xrefwindow id=d4405e2829 href="http://www.ncbi.nlm.nih.gov/pubmed/28287639">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2832 href="https://doi.org/10.1038/bmt.2017.34">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2836 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5467246">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718874812"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2846 class=n-a></a>Luznik L, O'Donnell PV, Symons HJ, <i> et al.</i>: HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. <i>Biol Blood Marrow Transplant.</i> 2008; <b>14</b>(6): 641–650. <a target=xrefwindow id=d4405e2857 href="http://www.ncbi.nlm.nih.gov/pubmed/18489989">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2860 href="https://doi.org/10.1016/j.bbmt.2008.03.005">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2864 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2633246">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718874812">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732542913"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2877 class=n-a></a>Ruggeri A, Labopin M, Bacigalupo A, <i> et al.</i>: Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. <i>Cancer.</i> 2018; <b>124</b>(7): 1428–1437. <a target=xrefwindow id=d4405e2888 href="http://www.ncbi.nlm.nih.gov/pubmed/29360162">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2891 href="https://doi.org/10.1002/cncr.31228">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732542913">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730450399"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2904 class=n-a></a>Castagna L, Bramanti S, Devillier R, <i> et al.</i>: Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma. <i>Bone Marrow Transplant.</i> 2017; <b>52</b>(5): 797. <a target=xrefwindow id=d4405e2915 href="http://www.ncbi.nlm.nih.gov/pubmed/28465624">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2918 href="https://doi.org/10.1038/bmt.2017.26">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730450399">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d4405e2931 class=n-a></a>Jacque N, Lambert J, Yakoub-Agha I, <i> et al.</i>: Comparison of Mobilized Peripheral Blood Stem Cells Versus Unmanipulated Bone Marrow Haploidentical Transplantation Using Post-Transplant Cyclophosphamide: A Retrospective Study of SFGM-TC in 176 Patients. <i>59th ASH Annual Meeting</i>. 2017. <a target=xrefwindow id=d4405e2939 href="https://ashpublications.org/blood/article/130/Supplement%201/2039/71254/Comparison-of-Mobilized-Peripheral-Blood-Stem">Reference Source</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727742173"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e2948 class=n-a></a>Bashey A, Zhang MJ, McCurdy SR, <i> et al.</i>: Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. <i>J Clin Oncol.</i> 2017; <b>35</b>(26): 3002–3009. <a target=xrefwindow id=d4405e2959 href="http://www.ncbi.nlm.nih.gov/pubmed/28644773">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2962 href="https://doi.org/10.1200/JCO.2017.72.8428">Publisher Full Text </a> | <a target=xrefwindow id=d4405e2966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5590802">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727742173">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d4405e2979 class=n-a></a>Bradstock K, Bilmon I, Kwan J, <i> et al.</i>: Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors. <i>Biol Blood Marrow Transplant.</i> 2015; <b>21</b>(9): 1641–1645. <a target=xrefwindow id=d4405e2990 href="http://www.ncbi.nlm.nih.gov/pubmed/26079442">PubMed Abstract </a> | <a target=xrefwindow id=d4405e2993 href="https://doi.org/10.1016/j.bbmt.2015.06.006">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d4405e3003 class=n-a></a>Shier LR, Schultz KR, Imren S, <i> et al.</i>: Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors. <i>Biol Blood Marrow Transplant.</i> 2004; <b>10</b>(9): 624–634. <a target=xrefwindow id=d4405e3014 href="http://www.ncbi.nlm.nih.gov/pubmed/15319774">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3017 href="https://doi.org/10.1016/j.bbmt.2004.05.009">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d4405e3026 class=n-a></a>Chang YJ, Zhao XY, Huo MR, <i> et al.</i>: Expression profiles of adhesion molecules on naïve T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor. <i>Transpl Immunol.</i> 2009; <b>21</b>(4): 228–233. <a target=xrefwindow id=d4405e3037 href="http://www.ncbi.nlm.nih.gov/pubmed/19467326">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3040 href="https://doi.org/10.1016/j.trim.2009.05.005">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d4405e3049 class=n-a></a>Ji SQ, Chen HR, Wang HX, <i> et al.</i>: Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. <i>Biol Blood Marrow Transplant.</i> 2002; <b>8</b>(5): 261–267. <a target=xrefwindow id=d4405e3060 href="http://www.ncbi.nlm.nih.gov/pubmed/12064363">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3063 href="https://doi.org/10.1053/bbmt.2002.v8.pm12064363">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d4405e3072 class=n-a></a>Isola L, Scigliano E, Fruchtman S: Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation. <i>Biol Blood Marrow Transplant.</i> 2000; <b>6</b>(4A): 428–433. <a target=xrefwindow id=d4405e3080 href="http://www.ncbi.nlm.nih.gov/pubmed/10975511">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3083 href="https://doi.org/10.1016/s1083-8791(00)70034-6">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d4405e3092 class=n-a></a>Couban S, Messner HA, Andreou P, <i> et al.</i>: Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients. <i>Biol Blood Marrow Transplant.</i> 2000; <b>6</b>(4A): 422–427. <a target=xrefwindow id=d4405e3103 href="http://www.ncbi.nlm.nih.gov/pubmed/10975510">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3106 href="https://doi.org/10.1016/s1083-8791(00)70033-4">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d4405e3115 class=n-a></a>Couban S, Aljurf M, Lachance S, <i> et al.</i>: Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study. <i>Biol Blood Marrow Transplant.</i> 2016; <b>22</b>(8): 1410–1415. <a target=xrefwindow id=d4405e3126 href="http://www.ncbi.nlm.nih.gov/pubmed/27154847">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3129 href="https://doi.org/10.1016/j.bbmt.2016.04.017">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1018919"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3139 class=n-a></a>Le Blanc K, Rasmusson I, Sundberg B, <i> et al.</i>: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. <i>Lancet.</i> 2004; <b>363</b>(9419): 1439–1441. <a target=xrefwindow id=d4405e3150 href="http://www.ncbi.nlm.nih.gov/pubmed/15121408">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3153 href="https://doi.org/10.1016/S0140-6736(04)16104-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1018919">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d4405e3166 class=n-a></a>Kebriaei P, Isola L, Bahceci E, <i> et al.</i>: Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. <i>Biol Blood Marrow Transplant.</i> 2009; <b>15</b>(7): 804–811. <a target=xrefwindow id=d4405e3177 href="http://www.ncbi.nlm.nih.gov/pubmed/19539211">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3180 href="https://doi.org/10.1016/j.bbmt.2008.03.012">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d4405e3189 class=n-a></a>Kurtzberg J, Prockop S, Teira P, <i> et al.</i>: Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. <i>Biol Blood Marrow Transplant.</i> 2014; <b>20</b>(2): 229–235. <a target=xrefwindow id=d4405e3200 href="http://www.ncbi.nlm.nih.gov/pubmed/24216185">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3203 href="https://doi.org/10.1016/j.bbmt.2013.11.001">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d4405e3212 class=n-a></a>Simmons P: A PIPELINE OF INNOVATIVE CELLULAR MEDICINES FOR CURRENTLY INTRACTABLE, ADVANCED-STAGE DISEASES. <i>International Society for Stem Cell Research Annual Meeting, 2018.</i> 2018. </span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d4405e3224 class=n-a></a>Polymeri A, Giannobile WV, Kaigler D: Bone Marrow Stromal Stem Cells in Tissue Engineering and Regenerative Medicine. <i>Horm Metab Res.</i> 2016; <b>48</b>(11): 700–713. <a target=xrefwindow id=d4405e3232 href="http://www.ncbi.nlm.nih.gov/pubmed/27871114">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3235 href="https://doi.org/10.1055/s-0042-118458">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d4405e3244 class=n-a></a>Steinert AF, Rackwitz L, Gilbert F, <i> et al.</i>: Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. <i>Stem Cells Transl Med.</i> 2012; <b>1</b>(3): 237–247. <a target=xrefwindow id=d4405e3255 href="http://www.ncbi.nlm.nih.gov/pubmed/23197783">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3258 href="https://doi.org/10.5966/sctm.2011-0036">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3262 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3659848">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d4405e3272 class=n-a></a>Veronesi F, Giavaresi G, Tschon M, <i> et al.</i>: Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease. <i>Stem Cells Dev.</i> 2013; <b>22</b>(2): 181–192. <a target=xrefwindow id=d4405e3283 href="http://www.ncbi.nlm.nih.gov/pubmed/23030230">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3286 href="https://doi.org/10.1089/scd.2012.0373">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d4405e3295 class=n-a></a>Naseri MH, Madani H, Ahmadi Tafti SH, <i> et al.</i>: COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial. <i>Cell J.</i> 2018; <b>20</b>(3): 449. <a target=xrefwindow id=d4405e3306 href="http://www.ncbi.nlm.nih.gov/pubmed/29845801">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3309 href="https://doi.org/10.22074/cellj.2018.6018">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6005993">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718267078"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3322 class=n-a></a>Nasseri BA, Ebell W, Dandel M, <i> et al.</i>: Autologous CD133<sup>+</sup> bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. <i>Eur Heart J.</i> 2014; <b>35</b>(19): 1263–1274. <a target=xrefwindow id=d4405e3336 href="http://www.ncbi.nlm.nih.gov/pubmed/24497345">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3340 href="https://doi.org/10.1093/eurheartj/ehu007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718267078">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d4405e3353 class=n-a></a>Steinhoff G, Nesteruk J, Wolfien M, <i> et al.</i>: Cardiac Function Improvement and Bone Marrow Response -: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133<sup>+</sup> Application After Myocardial Infarction. <i>EBioMedicine.</i> 2017; <b>22</b>: 208–224. <a target=xrefwindow id=d4405e3367 href="http://www.ncbi.nlm.nih.gov/pubmed/28781130">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3371 href="https://doi.org/10.1016/j.ebiom.2017.07.022">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3374 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5552265">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727624942"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3383 class=n-a></a>Zang L, Hao H, Liu J, <i> et al.</i>: Mesenchymal stem cell therapy in type 2 diabetes mellitus. <i>Diabetol Metab Syndr.</i> 2017; <b>9</b>: 36. <a target=xrefwindow id=d4405e3394 href="http://www.ncbi.nlm.nih.gov/pubmed/28515792">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3397 href="https://doi.org/10.1186/s13098-017-0233-1">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3401 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5433043">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727624942">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733382226"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3414 class=n-a></a>Gabr MM, Zakaria MM, Refaie AF, <i> et al.</i>: Insulin-producing Cells from Adult Human Bone Marrow Mesenchymal Stromal Cells Could Control Chemically Induced Diabetes in Dogs: A Preliminary Study. <i>Cell Transplant.</i> 2018; <b>27</b>(6): 937–947. <a target=xrefwindow id=d4405e3425 href="http://www.ncbi.nlm.nih.gov/pubmed/29860900">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3428 href="https://doi.org/10.1177/0963689718759913">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3432 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6050912">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733382226">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727139545"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3446 class=n-a></a>Bhansali S, Dutta P, Kumar V, <i> et al.</i>: Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. <i>Stem Cells Dev.</i> 2017; <b>26</b>(7): 471–481. <a target=xrefwindow id=d4405e3457 href="http://www.ncbi.nlm.nih.gov/pubmed/28006991">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3460 href="https://doi.org/10.1089/scd.2016.0275">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727139545">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737150193"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3473 class=n-a></a>Dahbour S, Jamali F, Alhattab D, <i> et al.</i>: Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy. <i>CNS Neurosci Ther.</i> 2017; <b>23</b>(11): 866–874. <a target=xrefwindow id=d4405e3484 href="http://www.ncbi.nlm.nih.gov/pubmed/28961381">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3487 href="https://doi.org/10.1111/cns.12759">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3491 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5698713">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737150193">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d4405e3504 class=n-a></a>Oh KW, Moon C, Kim HY, <i> et al.</i>: Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. <i>Stem Cells Transl Med.</i> 2015; <b>4</b>(6): 590–597. <a target=xrefwindow id=d4405e3515 href="http://www.ncbi.nlm.nih.gov/pubmed/25934946">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3518 href="https://doi.org/10.5966/sctm.2014-0212">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3522 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4449093">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d4405e3531 class=n-a></a>Nafissi S, Kazemi H, Tiraihi T, <i> et al.</i>: Intraspinal delivery of bone marrow stromal cell-derived neural stem cells in patients with amyotrophic lateral sclerosis: A safety and feasibility study. <i>J Neurol Sci.</i> 2016; <b>362</b>: 174–181. <a target=xrefwindow id=d4405e3542 href="http://www.ncbi.nlm.nih.gov/pubmed/26944143">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3545 href="https://doi.org/10.1016/j.jns.2016.01.051">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726911879"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3554 class=n-a></a>Cox CS Jr, Hetz RA, Liao GP, <i> et al.</i>: Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells. <i>Stem Cells.</i> 2017; <b>35</b>(4): 1065–1079. <a target=xrefwindow id=d4405e3565 href="http://www.ncbi.nlm.nih.gov/pubmed/27800660">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3568 href="https://doi.org/10.1002/stem.2538">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3572 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5367945">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726911879">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727429986"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3585 class=n-a></a>Hess DC, Wechsler LR, Clark WM, <i> et al.</i>: Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. <i>Lancet Neurol.</i> 2017; <b>16</b>(5): 360–368. <a target=xrefwindow id=d4405e3596 href="http://www.ncbi.nlm.nih.gov/pubmed/28320635">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3599 href="https://doi.org/10.1016/S1474-4422(17)30046-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727429986">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d4405e3613 class=n-a></a>Furuta T, Miyaki S, Ishitobi H, <i> et al.</i>: Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model. <i>Stem Cells Transl Med.</i> 2016; <b>5</b>(12): 1620–1630. <a target=xrefwindow id=d4405e3624 href="http://www.ncbi.nlm.nih.gov/pubmed/27460850">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3627 href="https://doi.org/10.5966/sctm.2015-0285">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3631 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5189643">Free Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d4405e3640 class=n-a></a>Qi X, Zhang J, Yuan H, <i> et al.</i>: Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats. <i>Int J Biol Sci.</i> 2016; <b>12</b>(7): 836–49. <a target=xrefwindow id=d4405e3651 href="http://www.ncbi.nlm.nih.gov/pubmed/27313497">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3654 href="https://doi.org/10.7150/ijbs.14809">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3658 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4910602">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727307908"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3667 class=n-a></a>Mead B, Tomarev S: Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms. <i>Stem Cells Transl Med.</i> 2017; <b>6</b>(4): 1273–1285. <a target=xrefwindow id=d4405e3675 href="http://www.ncbi.nlm.nih.gov/pubmed/28198592">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3678 href="https://doi.org/10.1002/sctm.16-0428">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3681 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5442835">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727307908">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d4405e3694 class=n-a></a>Rager TM, Olson JK, Zhou Y, <i> et al.</i>: Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis. <i>J Pediatr Surg.</i> 2016; <b>51</b>(6): 942–947. <a target=xrefwindow id=d4405e3705 href="http://www.ncbi.nlm.nih.gov/pubmed/27015901">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3708 href="https://doi.org/10.1016/j.jpedsurg.2016.02.061">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3712 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4921266">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726674566"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4405e3721 class=n-a></a>Zhang Y, Chopp M, Zhang ZG, <i> et al.</i>: Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. <i>Neurochem Int.</i> 2017; <b>111</b>: 69–81. <a target=xrefwindow id=d4405e3732 href="http://www.ncbi.nlm.nih.gov/pubmed/27539657">PubMed Abstract </a> | <a target=xrefwindow id=d4405e3735 href="https://doi.org/10.1016/j.neuint.2016.08.003">Publisher Full Text </a> | <a target=xrefwindow id=d4405e3739 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5311054">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726674566">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 17 Jan 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-26&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-26&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA, 98109, USA<br/> <sup>2</sup> Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute IRCCS, Milan, Italy<br/> <p> <div class=margin-bottom> Elisabetta Xue <br/> <span>Roles: </span> Conceptualization, Formal Analysis, Investigation, Resources, Visualization, Writing – Original Draft Preparation </div> <div class=margin-bottom> Filippo Milano <br/> <span>Roles: </span> Conceptualization, Investigation, Project Administration, Resources, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-26/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 17 Jan 2020, 9:26 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.20605.1">https://doi.org/10.12688/f1000research.20605.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Xue E and Milano F. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=22656 data-id=20605 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20605.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-26/v1/pdf?article_uuid=2f2e5087-1153-46f1-a43f-bd0f226b0720" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.20605.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Xue E and Milano F. Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):26 (<a href="https://doi.org/10.12688/f1000research.20605.1" target=_blank>https://doi.org/10.12688/f1000research.20605.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=20605 id=mobile-track-article-signin-20605 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20605?target=/articles/9-26"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22656 /> <input name=articleId type=hidden value=20605 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>David S. Allan</strong>, Department of Medicine, Faculty of Medicine, University of Ottawa, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> David S. Allan is the Medical Director of Stem Cells at Canadian Blood Services. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Michael Uhlin</strong>, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 17 Jan 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-26&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-26&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=62072-58279></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=62071-58278></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-26/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>17 Jan 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>David S. Allan</strong>, Department of Medicine, Faculty of Medicine, University of Ottawa, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> David S. Allan is the Medical Director of Stem Cells at Canadian Blood Services. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Michael Uhlin</strong>, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-26&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-26/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Are we underutilizing bone marrow and cord...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-26/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-26/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-26/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Xue E and Milano F');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-26/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-26",
            templates : {
                twitter : "Are we underutilizing bone marrow and cord blood? Review of their.... Xue E and Milano F, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-26/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/20605/22656")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "22656");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "58278": 1,
                           "58279": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "bfc1b15a-bc2e-4800-a73a-a8dca9161735";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-26.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-26.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-26.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-26.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-26.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>